Modalis Therapeutics Corp
TSE:4883

Watchlist Manager

Modalis Therapeutics Corp

TSE:4883

Watchlist

Dividends

Discount Rate

Price: 146 JPY -1.35% Market Closed

Market Cap: 9.4B JPY

Have any thoughts about
Modalis Therapeutics Corp?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Fubotv Inc NYSE:FUBO	Media
US	Bank of America Corp NYSE:BAC	Banking
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Uber Technologies Inc NYSE:UBER	Road & Rail
CN	NIO Inc NYSE:NIO	Automobiles
US	Fluor Corp NYSE:FLR	Construction
US	Jacobs Engineering Group Inc NYSE:J	Professional Services
US	TopBuild Corp NYSE:BLD	Consumer products
US	Abbott Laboratories NYSE:ABT	Health Care
US	Chevron Corp NYSE:CVX	Energy
US	Occidental Petroleum Corp NYSE:OXY	Energy
US	Matrix Service Co NASDAQ:MTRX	Construction
US	Automatic Data Processing Inc NASDAQ:ADP	Technology
US	Qualcomm Inc NASDAQ:QCOM	Semiconductors
US	PayPal Holdings Inc NASDAQ:PYPL	Technology
US	Ambarella Inc NASDAQ:AMBA	Semiconductors

Add Price Alert

Price Target:

Last Price: 146 JPY

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

Alert

Modalis Therapeutics Corp

146

-2 (-1.35%)

52 Week Range	63 173
Price Target

We'll email you a reminder when the closing price reaches JPY.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Fubotv Inc NYSE:FUBO	US
	Bank of America Corp NYSE:BAC	US
	Palantir Technologies Inc NYSE:PLTR	US
	Uber Technologies Inc NYSE:UBER	US
	NIO Inc NYSE:NIO	CN
	Fluor Corp NYSE:FLR	US
	Jacobs Engineering Group Inc NYSE:J	US
	TopBuild Corp NYSE:BLD	US
	Abbott Laboratories NYSE:ABT	US
	Chevron Corp NYSE:CVX	US
	Occidental Petroleum Corp NYSE:OXY	US
	Matrix Service Co NASDAQ:MTRX	US
	Automatic Data Processing Inc NASDAQ:ADP	US
	Qualcomm Inc NASDAQ:QCOM	US
	PayPal Holdings Inc NASDAQ:PYPL	US
	Ambarella Inc NASDAQ:AMBA	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Modalis Therapeutics Corp

What unique competitive advantages
does Modalis Therapeutics Corp hold over its rivals?

What risks and challenges
does Modalis Therapeutics Corp face in the near future?

Provide an overview of the primary business activities
of Modalis Therapeutics Corp.

Show me price targets
for Modalis Therapeutics Corp made by professional analysts.

Provide an overview of the primary business activities
of Modalis Therapeutics Corp.

What unique competitive advantages
does Modalis Therapeutics Corp hold over its rivals?

What risks and challenges
does Modalis Therapeutics Corp face in the near future?

Show all valuation multiples
for Modalis Therapeutics Corp.

Provide P/S
for Modalis Therapeutics Corp.

Provide P/E
for Modalis Therapeutics Corp.

Provide P/OCF
for Modalis Therapeutics Corp.

Provide P/FCFE
for Modalis Therapeutics Corp.

Provide P/B
for Modalis Therapeutics Corp.

Provide EV/S
for Modalis Therapeutics Corp.

Provide EV/GP
for Modalis Therapeutics Corp.

Provide EV/EBITDA
for Modalis Therapeutics Corp.

Provide EV/EBIT
for Modalis Therapeutics Corp.

Provide EV/OCF
for Modalis Therapeutics Corp.

Provide EV/FCFF
for Modalis Therapeutics Corp.

Provide EV/IC
for Modalis Therapeutics Corp.

Show me price targets
for Modalis Therapeutics Corp made by professional analysts.

What are the Revenue projections
for Modalis Therapeutics Corp?

How accurate were the past Revenue estimates
for Modalis Therapeutics Corp?

What are the Net Income projections
for Modalis Therapeutics Corp?

How accurate were the past Net Income estimates
for Modalis Therapeutics Corp?

What are the EPS projections
for Modalis Therapeutics Corp?

How accurate were the past EPS estimates
for Modalis Therapeutics Corp?

What are the EBIT projections
for Modalis Therapeutics Corp?

How accurate were the past EBIT estimates
for Modalis Therapeutics Corp?

Compare the revenue forecasts
for Modalis Therapeutics Corp with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Modalis Therapeutics Corp and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Modalis Therapeutics Corp against its competitors.

Analyze the profit margins
(gross, operating, and net) of Modalis Therapeutics Corp compared to its peers.

Compare the P/E ratios
of Modalis Therapeutics Corp against its peers.

Discuss the investment returns and shareholder value creation
comparing Modalis Therapeutics Corp with its peers.

Analyze the financial leverage
of Modalis Therapeutics Corp compared to its main competitors.

Show all profitability ratios
for Modalis Therapeutics Corp.

Provide ROE
for Modalis Therapeutics Corp.

Provide ROA
for Modalis Therapeutics Corp.

Provide ROIC
for Modalis Therapeutics Corp.

Provide ROCE
for Modalis Therapeutics Corp.

Provide Gross Margin
for Modalis Therapeutics Corp.

Provide Operating Margin
for Modalis Therapeutics Corp.

Provide Net Margin
for Modalis Therapeutics Corp.

Provide FCF Margin
for Modalis Therapeutics Corp.

Show all solvency ratios
for Modalis Therapeutics Corp.

Provide D/E Ratio
for Modalis Therapeutics Corp.

Provide D/A Ratio
for Modalis Therapeutics Corp.

Provide Interest Coverage Ratio
for Modalis Therapeutics Corp.

Provide Altman Z-Score Ratio
for Modalis Therapeutics Corp.

Provide Quick Ratio
for Modalis Therapeutics Corp.

Provide Current Ratio
for Modalis Therapeutics Corp.

Provide Cash Ratio
for Modalis Therapeutics Corp.

What is the historical Revenue growth
over the last 5 years for Modalis Therapeutics Corp?

What is the historical Net Income growth
over the last 5 years for Modalis Therapeutics Corp?

What is the current Free Cash Flow
of Modalis Therapeutics Corp?

Discuss the annual earnings per share (EPS)
trend over the past five years for Modalis Therapeutics Corp.

Modalis Therapeutics Corp

Balance Sheet

Common Shares Outstanding

Modalis Therapeutics Corp
Common Shares Outstanding

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

Adjust for Inflation

Modalis Therapeutics Corp
Common Shares Outstanding Peer Comparison

Comparables:

2160

4587

4974

2929

4894

Competitive Common Shares Outstanding Analysis
Latest Figures & CAGR of Competitors

Company		Common Shares Outstanding	CAGR 3Y	CAGR 5Y	CAGR 10Y
	Modalis Therapeutics Corp TSE:4883	Common Shares Outstanding ¥33.4m	CAGR 3-Years 5%	CAGR 5-Years 11%	CAGR 10-Years N/A
	GNI Group Ltd TSE:2160	Common Shares Outstanding ¥50.1m	CAGR 3-Years 2%	CAGR 5-Years 4%	CAGR 10-Years 4%
	PeptiDream Inc TSE:4587	Common Shares Outstanding ¥129.6m	CAGR 3-Years 0%	CAGR 5-Years 1%	CAGR 10-Years 2%
	Takara Bio Inc TSE:4974	Common Shares Outstanding ¥120.4m	CAGR 3-Years 0%	CAGR 5-Years 0%	CAGR 10-Years 0%
	Pharma Foods International Co Ltd TSE:2929	Common Shares Outstanding ¥28.1m	CAGR 3-Years -1%	CAGR 5-Years -1%	CAGR 10-Years 0%
C	Cuorips Inc TSE:4894	Common Shares Outstanding ¥8m	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years N/A

What is Modalis Therapeutics Corp's Common Shares Outstanding?

Common Shares Outstanding
33.4m JPY

Based on the financial report for Dec 31, 2023, Modalis Therapeutics Corp's Common Shares Outstanding amounts to 33.4m JPY.

What is Modalis Therapeutics Corp's Common Shares Outstanding growth rate?

Common Shares Outstanding CAGR 5Y
11%

Over the last year, the Common Shares Outstanding growth was 14%. The average annual Common Shares Outstanding growth rates for Modalis Therapeutics Corp have been 5% over the past three years , 11% over the past five years .

Modalis Therapeutics Corp
TSE:4883

Modalis Therapeutics Corp
Common Shares Outstanding

Modalis Therapeutics Corp
Common Shares Outstanding Peer Comparison

Competitive Common Shares Outstanding Analysis
Latest Figures & CAGR of Competitors

See Also

What is Modalis Therapeutics Corp's Common Shares Outstanding?

Common Shares Outstanding
33.4m JPY

What is Modalis Therapeutics Corp's Common Shares Outstanding growth rate?

Common Shares Outstanding CAGR 5Y
11%

Company

Help

Tools

Stocks

Modalis Therapeutics Corp TSE:4883

Modalis Therapeutics Corp Common Shares Outstanding

Modalis Therapeutics Corp Common Shares Outstanding Peer Comparison

Competitive Common Shares Outstanding Analysis Latest Figures & CAGR of Competitors

See Also

What is Modalis Therapeutics Corp's Common Shares Outstanding? Common Shares Outstanding 33.4m JPY

What is Modalis Therapeutics Corp's Common Shares Outstanding growth rate? Common Shares Outstanding CAGR 5Y 11%

Company

Help

Tools

Stocks

Modalis Therapeutics Corp
TSE:4883

Modalis Therapeutics Corp
Common Shares Outstanding

Modalis Therapeutics Corp
Common Shares Outstanding Peer Comparison

Competitive Common Shares Outstanding Analysis
Latest Figures & CAGR of Competitors

What is Modalis Therapeutics Corp's Common Shares Outstanding?

Common Shares Outstanding
33.4m JPY

What is Modalis Therapeutics Corp's Common Shares Outstanding growth rate?

Common Shares Outstanding CAGR 5Y
11%